Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus

Autor: Xie, S-H, Fang, R, Huang, M, Dai, J, Thrift, AP, Anderson, LA, Chow, W-H, Bernstein, L, Gammon, MD, Risch, HA, Shaheen, NJ, Reid, BJ, Wu, AH, Iyer, PG, Liu, G, Corley, DA, Whiteman, DC, Caldas, C, Pharoah, PD, Hardie, LJ, Fitzgerald, RC, Shen, H, Vaughan, TL, Lagergren, J
Jazyk: angličtina
Rok vydání: 2020
ISSN: 1542-3565
Popis: Background & Aims Esophageal adenocarcinoma (EAC) occurs most frequently in men. We performed a Mendelian randomization analysis to investigate whether genetic factors that regulate levels of sex hormones associated with risk of EAC or Barrett’s esophagus (BE). Methods We conducted a Mendelian randomization analysis using data from patients with EAC (n=2488) or BE (n=3247) and control participants (n=2127), included in international consortia of genome-wide association studies in Australia, Europe, and North America. Genetic risk scores or single nucleotide variants were used as instrumental variables for 9 specific sex hormones. Logistic regression provided odds ratios (ORs) with 95% CIs. Results Higher genetically predicted levels of follicle stimulating hormones were associated with increased risks of EAC and/or BE in men (OR, 1.14 per allele increase; 95% CI, 1.01-1.27) and in women (OR, 1.28; 95% CI, 1.03-1.59). Higher predicted levels of luteinizing hormone were associated with a decreased risk of EAC in men (OR, 0.92 per standard deviation increase; 95% CI, 0.87-0.99) and in women (OR, 0.93; 95% CI, 0.79-1.09), and decreased risks of BE (OR, 0.88; 95% CI, 0.77-0.99) and EAC and/or BE (OR, 0.89; 95% CI, 0.79-1.00) in women. We found no clear associations for other hormones studied, including sex hormone-binding globulin, dehydroepiandrosterone sulphate, testosterone, dihydrotestosterone, estradiol, progesterone, or free androgen index. Conclusions In a Mendelian randomization analysis of data from patients with EAC or BE, we found an association between genetically predicted levels of follicle stimulating and luteinizing hormones and risk of BE and EAC.
Databáze: OpenAIRE